C
Carol Black
Researcher at Royal College of Physicians
Publications - 24
Citations - 1174
Carol Black is an academic researcher from Royal College of Physicians. The author has contributed to research in topics: Health care & Bosentan. The author has an hindex of 8, co-authored 24 publications receiving 1151 citations. Previous affiliations of Carol Black include Royal Free Hospital.
Papers
More filters
Journal ArticleDOI
Survival with first-line bosentan in patients with primary pulmonary hypertension
Vv Mclaughlin,Olivier Sitbon,Db Badesch,Rj Barst,Carol Black,Nazzareno Galiè,Maurizio Rainisio,Gérald Simonneau,LJ Rubin +8 more
TL;DR: First-line bosentan therapy was found to improve survival in patients with advanced primary pulmonary hypertension, and factors that predicted a worse outcome included World Health Organization Functional Class IV and 6-min walk distance below the median at baseline.
Journal ArticleDOI
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
Olivier Sitbon,Vallerie V. McLaughlin,David B. Badesch,Robyn J. Barst,Carol Black,Nazzareno Galiè,Marc Humbert,Maurizio Rainisio,Lewis J. Rubin,Gérald Simonneau +9 more
TL;DR: No evidence was found to suggest that initial treatment with oral bosentan, followed by or with the addition of other treatment if needed, adversely affected the long term outcome compared with initial intravenous epoprostenol in patients with class III idiopathic PAH.
Journal ArticleDOI
Mechanisms and consequences of fibrosis in systemic sclerosis.
TL;DR: Overall, this is an exciting time for new therapies in SSc and advances are being made in synchrony with an improved understanding of the molecular and biochemical basis of the disease.
Journal ArticleDOI
Sitaxsentan for the treatment of pulmonary arterial hypertension: A 1-year, prospective, open-label observation of outcome and survival
Raymond L. Benza,Robyn J. Barst,Nazzareno Galiè,Adaani E. Frost,Reda E. Girgis,Kristin B. Highland,Charlie Strange,Carol Black,David B. Badesch,Lewis J. Rubin,Thomas R. Fleming,Robert Naeije +11 more
TL;DR: In this article, the authors presented 1-year observational data with two endothelin antagonists, sitaxsentan and bosentan, in a prospective, open-label study.
Journal ArticleDOI
Acute medicine: making it work for patients.
TL;DR: The report of a working party of the Royal College of Physicians, Acute Medicine: making it work for patients, seeks to improve hospital care of patients who are acutely ill and highlights the developing role of consultant physicians in acute medicine.